We are live on ! Find out more
BDWM

Brewin Dolphin Wealth Management Portfolio holdings

AUM $917M
1-Year Est. Return 12.3%
This Fund
S&P 500
This Quarter Est. Return
+10.17%
1 Year Est. Return
-12.3%
3 Year Est. Return
+47.8%
5 Year Est. Return
+88.28%
10 Year Est. Return
AUM
$823M
AUM Growth
+$168M
Cap. Flow
+$100M
Cap. Flow %
12.17%
Top 10 Hldgs %
56.65%
Holding
352
New
32
Increased
90
Reduced
37
Closed
17

Sector Composition

Rank Sector Weight
1 Financials 21.79%
2 Technology 12.73%
3 Healthcare 9.05%
4 Communication Services 8.26%
5 Consumer Discretionary 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EDIT icon
301
Editas Medicine
EDIT
$445M
$8.5K ﹤0.01%
150
SPRO icon
302
Spero Therapeutics
SPRO
$73.5M
$8.38K ﹤0.01%
600
STEX
303
Streamex Corp
STEX
$75.3M
$7.72K ﹤0.01%
200
PANW icon
304
Palo Alto Networks
PANW
$293B
$6.68K ﹤0.01%
108
RNAM
305
DELISTED
Avidity Biosciences
RNAM
$6.67K ﹤0.01%
270
KYNB
306
Kyntra Bio
KYNB
$28.3M
$6.66K ﹤0.01%
10
BYND icon
307
Beyond Meat
BYND
$272M
$6.62K ﹤0.01%
+42
New +$5.58K
INFN
308
DELISTED
Infinera Corporation Common Stock
INFN
$6.12K ﹤0.01%
600
AGC
309
DELISTED
Altimeter Growth Corp
AGC
$5.85K ﹤0.01%
+500
New +$6.12K
SDGR icon
310
Schrodinger
SDGR
$1.33B
$5.59K ﹤0.01%
74
TMPO
311
DELISTED
Tempo Automation Holdings, Inc. Common Stock
TMPO
$5.58K ﹤0.01%
560
KL
312
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$5.2K ﹤0.01%
135
TAK icon
313
Takeda Pharmaceutical
TAK
$54.4B
$5.05K ﹤0.01%
300
RDS.B
314
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$5.01K ﹤0.01%
129
DKNG icon
315
DraftKings
DKNG
$11B
$4.8K ﹤0.01%
+92
New +$4.85K
XPEV icon
316
XPeng
XPEV
$11.2B
$4.44K ﹤0.01%
+100
New +$3.41K
AKTS
317
DELISTED
Akoustis Technologies Inc
AKTS
$4.39K ﹤0.01%
410
CVET
318
DELISTED
Covetrus, Inc. Common Stock
CVET
$4.32K ﹤0.01%
160
DBX icon
319
Dropbox
DBX
$8.06B
$4.09K ﹤0.01%
135
CCL icon
320
Carnival Corporation Ltd
CCL
$39.4B
$3.95K ﹤0.01%
150
PJT icon
321
PJT Partners
PJT
$4.42B
$3.57K ﹤0.01%
50
AMRN
322
Amarin Corp
AMRN
$301M
$3.5K ﹤0.01%
40
ARKG icon
323
ARK Genomic Revolution ETF
ARKG
$1.63B
$3.42K ﹤0.01%
37
CONE
324
DELISTED
CyrusOne Inc Common Stock
CONE
$3.22K ﹤0.01%
45
CGC
325
Canopy Growth
CGC
$394M
$2.66K ﹤0.01%
11

Similar funds

Brewin Dolphin Wealth Management's Q2 2021 Portfolio in Review

As of Q2 2021, Brewin Dolphin Wealth Management held 352 positions worth $823M, up 26% from $655M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Brewin Dolphin Wealth Management deployed $100M of net new capital in Q2 2021, opening 32 new positions and adding to 90 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 16,329 shares worth $887K.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $536K trimmed.

  • Brewin Dolphin Wealth Management's largest Q2 2021 buy was Vanguard FTSE Emerging Markets ETF: 16,329 shares worth $887K.
  • Brewin Dolphin Wealth Management added most to Berkshire Hathaway Class B in Q2 2021, an estimated $9.24M increase.
  • Brewin Dolphin Wealth Management's biggest Q2 2021 reduction was Pfizer, cutting an estimated $536K.
  • Brewin Dolphin Wealth Management fully exited BioXcel Therapeutics in Q2 2021, selling an estimated $86.3K.
  • Brewin Dolphin Wealth Management's ten largest holdings make up 57% of its $823M portfolio in Q2 2021.
  • Brewin Dolphin Wealth Management opened 32 new positions and closed 17 in Q2 2021.
  • Brewin Dolphin Wealth Management's portfolio value rose 26% quarter-over-quarter to $823M.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2021, filed 9 Nov 2023.